IMCD Buys US-based Mutchler

Foto: AVAVA/Shutterstock
Foto: AVAVA/Shutterstock

Just a day after announcing the purchase of Kenya’s Chemicals and Solvents,  Dutch specialty chemicals distributor IMCD said it has acquired US pharmaceutical industry supplier Mutchler. The US company Mutchler is a leading distributor of specialty pharmaceutical ingredients in both the continental US and Puerto Rico. Altogether, it has around 30 employees and posted 2015 revenue of $28 million.

IMCD said Mutchler is an excellent fit, given its asset-light business model and long-term relationships with leading global suppliers. “Following the acquisition of MF Cachat (now IMCD US) in June 2015, this is an important next step as it expands our US operations into the pharmaceutical market, a strategic sector for IMCD,” said Marcus Jordan, president of IMCD Holdings US.

Financial terms of the deal were not disclosed.

Free Expert Insights

Dual‑Targeting Breakthroughs
Advancements in Bispecific Antibody Development

Dual‑Targeting Breakthroughs

Unlock the latest breakthroughs in bispecific antibody development! Download Wiley’s free Expert Insights eBook to explore cutting-edge dual-targeting strategies, advanced purification methods, and bioanalytical technologies transforming immunotherapy and cancer treatment.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.